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South Asian countries report the highest prevalence of common mental disorders (CMDs)
globally. This systematic review and meta-analysis report the pooled prevalence of CMDs
among the South Asian countries. Database searches were conducted in eight electronic
databases. Titles, abstracts, full-text screening, and extraction of data on the event rate of
17 indicators of CMDs were performed by two independent reviewers. A total of 160
studies were included and data analysis was done using the Comprehensive Meta-
analysis Software (v.3). A prevalence of depressive symptoms was 26.4% among
173,449 participants, alcohol abuse was 12.9% (n = 107,893); anxiety 25.8% (n =
70,058); tobacco smoking 18.6% (n = 84,965); PTSD 17.2% (n = 42,298); mixed anxiety
and depression 28.4% (n = 11,102); suicidal behaviors 6.4% (n = 25,043); misuse of
opiates 0.8% (n = 37,304); tobacco chewing 21.0% (n = 10,586); use of cannabis 3% (n =
10,977); GAD 2.9% (n = 70,058); bipolar disorder 0.6% (n = 7,197); IV drug abuse 2.5%
(n = 15,049); panic disorder 0.01% (n = 28,087); stimulant use 0.9% (n = 1,414); OCD
1.6% (n = 8,784) and phobic disorders 1.8% (n = 27,754). This study reported a high
prevalence of CMDs in South Asian countries; necessitating further research on
psychiatric epidemiology in those contexts. It informs the need for effective
policymaking and implementation of culturally appropriate multilevel interventions.
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Mental disorders are highly prevalent across the globe, especially in low- andmiddle-income countries
(LMICs) (1). The World Health Organization’s Mental Health Gap Action Programme (mhGAP)
identifies depression, bipolar affective disorder, schizophrenia, and other psychotic disorders,
dementia, intellectual disabilities, and developmental disorders like autism as priority mental and
neurological disorders (1). These common mental disorders (CMDs) are associated with significant
functional impairment as well as social and economic consequences (1). It is estimated that depressiong September 2020 | Volume 11 | Article 5731501
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the global economy (2). Although CMDs are common worldwide,
a higher proportion (~80%) of people with mental health disorders
reside in LMICs (3), where these account for 8.8% to 16.6% of the
total burden of diseases (4). The negative implications of CMDs
are further compounded by a high treatment gap; 76% to 85% of
people with a mental disorder in low-income countries receive no
treatment for their disorder compared to 35%, and 50% of people
with mental disorders in high-income countries (1).
South Asian countries comprise one-quarter of the world’s
population and include countries like India, Pakistan, Nepal, Sri
Lanka, Bhutan, Bangladesh, Afghanistan, and the Maldives,
comprise one-quarter of the world’s population (5, 6). Marred
by high poverty rates approximately 150–200 million people in
this region have a diagnosed psychiatric disorder and limited
access to mental health (6). Despite the significant burden of
illness, the mental health infrastructure in this region is relatively
weak, with less than 1% of the total national budgets allocated to
it (7). There is also a shortage of psychiatrists and other mental
health professionals, clinical psychologists, as well as social
workers (6). A study estimates that the median number of
mental health providers in this region is 5.3 per 100,000
population, almost half of the overall global median (8). There
is only one psychiatrist per 100,000 population in nine out of the
11 countries in this region (8). In addition to the limitations in
resource allocation, the lack of community awareness toward
mental health and prevailing stigma further limits the number of
patients that actively seek health care (9).
South Asia has a diverse and rapidly growing population of
people from different cultures, religions, and socioeconomic
backgrounds (10). However, the information available
regarding the prevalence of psychiatric disorders in South Asia
is scant. In the past, a few studies have estimated the prevalence
and burden of psychiatric disorders in this region. A meta-
analysis reported that the total prevalence of mental disorders in
India is 58.2 per 1,000 people (11). In Bangladesh, the prevalence
of mental disorders varied from 6.5% to 31.0% among adults
(12). The epidemiological data related to mental disorders for Sri
Lanka, Afghanistan, and Bhutan is limited; only a few published
articles provide an estimate of the prevalence of psychiatric
illness in these countries. There is a lack of synthesized
evidence on the epidemiological burden of CMDs in this
region. This systematic review and meta-analysis acknowledged
this knowledge gap and aimed to understand the prevailing
trends of mental disorders in South Asian countries. The
present review has sought to identify the literature on the
prevalence of psychiatric disorders in the South Asian
countries published over a decade. This information would be
helpful for future policymaking and implementation of effective
health care measures to improve mental health in the region.MATERIALS AND METHODS
This systematic review was conducted as per the updated
PRISMA guidelines (13) and the protocol registered inFrontiers in Psychiatry | www.frontiersin.org 2PROSPERO (CRD42019130662). An electronic search was
conducted in eight electronic databases including PubMed,
Scopus, ISI Web of Science, POPLINE, New York Academy of
Medicine Grey Literature Report (NYAM), PsycINFO,
PsycARTICLES and the Cumulative Index to Nursing and
Allied Health Literature (CINAHL) on March 31, 2019, using
following search terms:
[(“Prevalence” OR “Frequency” OR epidemiology OR
epidemiological OR proportion) AND (“Mood disorder”
OR “Depression” OR “Substance abuse” OR “substance use”
OR “Posttraumatic stress disorder” OR PTSD OR “obsessive-
compulsive disorder” OR “OCD” OR”bipolar disorder” OR
“Anxiety” OR “Panic disorder” OR “schizophrenia”
OR “GAD” OR “Acute stress disorders”) AND (“South Asia”
OR “Afghanistan” OR “Nepal” OR “Pakistan” OR “India” OR
“Sri Lanka” OR “Bhutan” OR “Bangladesh” OR “Maldives”)].
We only included studies that were published in the last 10
years, i.e., from 2009 to 2019. No restriction of language was
applied. Three independent reviewers screened the databases for
eligible studies based on their titles and abstracts, followed by the
screening of full texts. All discrepancies among reviewers were
resolved through discussion between reviewers and guidance
from a senior author (SN).
Inclusion and Exclusion Criteria
All studies reporting the prevalence of common psychiatric
disorders among adults (≥18 years of age) including major
depressive disorder, substance abuse, and related disorder,
post-traumatic stress disorder, obsessive-compulsive disorder,
bipolar disorder, panic disorder, schizophrenia, and generalized
anxiety disorder were considered. Only those studies were
considered that reported from any country within South Asia
(i.e., Afghanistan, Bangladesh, Bhutan, India, Maldives, Nepal,
Pakistan, and Sri Lanka). To obtain precise estimates of
prevalence considered sufficiently powered studies with a
minimum sample size of 250. Data regarding any specialized
population (for example, depression among patients with a
primary diagnosis of heart failure, cancer, stroke, etc.) was not
included in this study. Only those studies were selected that were
published between 2009 and 2019 to inform our review with
the latest evidence base published from the South Asian
region. Only original cross-sectional investigations or baseline
data of longitudinal cohort studies were considered; which
applied census or either probabilistic or non-probabilistic
epidemiological procedures to ascertain prevalence CMDs.
Essentially, we used cross-sectional data to extract point
prevalence estimates. While from prospective studies, we
extracted point or period prevalence estimates and lifetime
prevalence estimates from most recent publications from
the cohort.
Data Extraction and Risk of
Bias Assessment
All the data were extracted independently by three teams of
reviewers using manual data extraction forms, and any
disagreement among the reviewers was resolved throughSeptember 2020 | Volume 11 | Article 573150
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author, year of publication, study design, setting, geographical
scope, educational and income level, country of study,
percentage of male participants, and characteristics of study
participants were extracted. Moreover, the data regarding the
psychiatric disorder studied, mode and type of diagnostic
interview, screening instruments, cut-off scores of the
screening instruments, sampling techniques, sample size,
response rates, and the number of participants with psychiatric
and comorbid medical disorders was also tabulated.
Three teams of reviewers (AC, SK, NA, SS, NJ, and RA)
assessed the quality of the studies independently without
blinding to authorship or journal. At this stage, discrepancies
in decision-making were resolved by discussion in conjunction
with the senior author (SN). The risk of bias across studies was
evaluated by using a modified version of the Newcastle Ottawa
Scale (14), across the following matrices: representativeness of
the study population, appropriate sample size, percentage
of non-respondents, quality of tools used for the ascertainment
of mental disorder, quality of reporting of descriptive statistics,
informed consent, and reporting of appropriate ethical
approval procedures.
Data Analysis
Descriptive statistics on the characteristics of the study and
populations were reported. Comprehensive meta-analysis
software was used to run a series of meta-analyses to pool
prevalence of specific mental disorders, using random-effects
analysis (15). Due to anticipated heterogeneity in data owing to
the use of different classification systems and psychometric scales
to assess mental disorders, we employed random effects for meta-
analysis throughout (16). Sensitivity analyses were conducted by
excluding individual studies individually to ascertain their effects
on the pooled prevalence. Begg’s funnel plot and Egger’s
regression statistics (significant at P < 0.10) were used in
evaluating publication bias (17), which was adjusted for by
using Duvall & Tweedie’s Trim and Fill method (18). To
ensure an appropriate statistical power, subgroup analyses were
conducted for subgroups reported in more than four studies per
outcome and meta-regression to identify significant moderators
of prevalence when there were more than ten studies (19).RESULTS
The initial literature search revealed 1,827 unique citations,
among which 160 studies met the inclusion criteria of
our meta-analytical studies. Figure 1 elaborates the screening
and selection process in the PRISMA flow diagram and
Supplementary Table 1 provides citations of all included
studies. Among the included studies, only four had a
longitudinal study design while the rest were cross-sectional
studies. A majority of these studies were conducted in
community settings (n = 133), followed by primary care
centers (n = 11), tertiary care centers (n = 6), refugee settings
(n = 2), and others (n = 8). A total of 67 studies were from urbanFrontiers in Psychiatry | www.frontiersin.org 3settings, rural (n = 31), national (n = 8), provincial (n = 2), semi-
urban (n = 4), and rest were conducted in mixed settings (n =
47). Participants in these studies were educated at undergraduate
levels (n = 27), high school (n = 4), graduate (n = 4), and
mixed (n = 97) while it was not mentioned in 28 studies.
The highest proportion of these studies was conducted in India
(n = 81) followed by Pakistan (n = 33), Nepal (n = 20), Sri Lanka
(n = 12), Bangladesh (n = 8), while 6 were conducted across
multiple countries. Supplementary Table 2 summarizes the
sociodemographic characteristics of participants included in
the studies. A majority of the studies used scales to screen for
mental disorders while 37 studies used diagnostic interviews
based on DSM-IV (n = 12), ICD-10 (n = 12), ICD-11 (n = 1),
MINI (n = 7), and composite international diagnostic interview
(n = 5). The highest proportion of studies (n = 89) included face
to face interviews, pencil based self-administered interviews (n =
65), and online surveys (n = 5). A variety of rating scales were
used to assess these disorders.
We assessed the pooled prevalence for 17 different mental
disorders over a period of 10 years. All the outcomes presented
significant heterogeneity ranging from 0% to 99.79% for
stimulant use and alcohol abuse, respectively. The prevalence
of depressive symptoms was reported in 135 studies (I2 =
99.53%) yielding a prevalence of 26.4% among 173,449
participants. Alcohol abuse was reported in 43 studies yielding
a prevalence of 12.9% (8.8–18.6%, I2 = 99.79%, n = 107893);
anxiety 25.8% (19.4% to 33.5%, I2 = 99.57%, n = 70,058); tobacco
smoking 18.6% (14.3% to 24%, I2 = 99.58%, n = 84965); PTSD
17.2% (11% to 25.9%, I2 = 99.55%, n = 42298); mixed anxiety and
depression 28.4% (13.9% to 49.3%, I2 = 99.41%, n = 11102);
suicidal behaviors 6.4% (3.1% to 12.4%, I2 = 99.41%, n = 25043);
misuse of opiates 0.8% (0.2% to 2.5%, I2 = 99.06%, n = 37304);
tobacco chewing 21.0% (14.0% to 30.3%, I2 = 98.49%, n = 10586);
use of cannabis 3% (1.5% to 7.0%, I2 = 97.48%, n = 10977); GAD
2.9% (0.3% to 26.5%, I2 = 99.57%, n = 70058); bipolar disorder
0.6% (0.3% to 1.0%, I2 = 78.21%, n = 7197); IV drug abuse 2.5%
(0.1% to 32.1%, I2 = 99.72%, n = 15049); Panic disorder 0.01%
(0.05% to 0.3%, I2 = 95.43%, n = 28087); stimulant use 0.9%
(0.5% to 1.6%, I2 = 0%, n = 1414); OCD 1.6% (0.4% to 5.5%, I2 =
96.57%, n = 8784) and phobic disorders 1.8% (0.4% to 7.1%, I2 =
98.16%, n = 27754). Supplementary Figures 1–12 represent the
forest plots for the above-mentioned disorders.
A meta-regression was conducted which revealed a significant
geographical variation in the prevalence of CMDs, explaining
15% of the variation in total between-study variance. Taking
Bangladesh as a reference point, the highest burden of mental
illnesses was reported in Pakistan (B = 1.96). Nepal and Sri Lanka
also reported a higher prevalence than Bangladesh. Moreover, no
significant differences in the prevalence of CMDs were reported
between Bangladesh and India. Table 1 represents the findings of
pooled prevalence for mental disorders in South Asia. Table 2
represents the findings from Meta-regression analysis exhibiting
South Asian countries as moderators of pooled prevalence of
mental disorders in South Asia. Further meta-regression analyses
did not reveal any association between prevalence estimates of all
mental disorders with the year of publication (B = 0.04, P = 0.24,September 2020 | Volume 11 | Article 573150
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males or female participants. Meta-regression analysis revealed
that the percentage of males in the study explained 3% of the
variation in heterogeneity (B = −0.02, P ≤ 0.001). These meta-
regression plots are presented as Supplementary Figures 1
and 2.
Subgroup analyses were conducted for several factors,
showing large variations in prevalence estimates across
different subgroups (Table 3). Studies employing diagnostic
interviews presented a significantly lower prevalence rate of
5.22% when compared with questionnaire-based surveys
(19.14%). Studies conducted in healthcare settings reported a
much higher prevalence rate of CMDs than its counterparts
conducted in the community or refugee settings. Studies
employing random sampling procedures than non-randomFrontiers in Psychiatry | www.frontiersin.org 4and having cross-sectional study designs reported lower
prevalence rates.
In the risk of bias assessment, most studies (60%, n = 96)
scored eight and above, which informs a low risk of bias across
the recruited studies. Furthermore, a funnel plot of the standard
error by logit event rate among studies showed publication bias
in the literature, with a significant Egger’s regression statistic
(Intercept = −3.14, P < 0.01). Figure 2 presents the funnel plot
showing studies currently present and imputed in the analysis.
The pooled estimate for prevalence was adjusted by imputing 32
studies to the left of the mean, yielding an adjusted prevalence of
11.31% (10.05% to 12.69%).
The quality of the studies was measured across nine matrices:
representativeness of the population, adequacy of sample size,
reporting of characteristics of non-respondents, use of aFIGURE 1 | PRISMA flow diagram.September 2020 | Volume 11 | Article 573150
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reporting of reliability measure and valid measure of scales,
reporting of descriptive statistics, reporting of the method of
informed consent and ethical approval. According to it, only 111
of the studies surveyed among populations that were
representative of their setting, 122 reported ethical approval
status, 126 characteristics of respondents, use of commonly
employed methods for the ascertainment of mental disorder
(n = 132), use of reliable (n = 136) and valid tool (n = 136),
reporting informed consent procedures (n = 145), descriptive
statistics (n = 146), and adequate sample size (n = 158). Overall, a
small proportion of studies (n = 16) reported < 5 of these
matrices, 6–8 (n = 90), and 56 scored positively on all of
these criteria.DISCUSSION
Summary
South Asian countries have a high disease burden of psychiatric
illnesses. Our study showed a prevalence of 14.2% (12.9% to
15.7%) for CMDs. This is higher compared to the worldwide-
pooled prevalence of mental disorders was 13.4% (20). Our
findings show the substantial public health burden of
psychiatric disorders in South Asian populations. TheseFrontiers in Psychiatry | www.frontiersin.org 5findings may have significance for the mental health
professionals as well as health policymakers of South
Asian nations.
Comparison With Previous Literature
The total prevalence of depressive symptoms in South Asian
countries was reported in 135 studies, yielding a prevalence of
26.4% (23.6% to 29.4%) among 173,449 participants which is
significantly higher than a previous study presenting data from
30 countries (15, 16). Moreover, our study reported a 6.4%
prevalence of suicidal behaviors in South Asia. Prevalence
estimates in developing countries are similar to those in
developed countries for: suicidal ideation (3.1% to 12.4%
versus 3.0% to 15.9%, respectively), suicide plan (0.9% to 4.1%
vs. 0.7% to 5.6%, respectively), and suicide attempt (0.7% to 4.7%
vs. 0.5% to 5.0%, respectively) (17). The suicide rate varies greatly
between countries with different development levels. For South
Asia, the countries with more accessible suicide data, overall
mortality, and cause of death data reported higher national
suicide rates. Therefore, it is likely that the current rate of
suicide can be attributed to inaccurate or under-reporting of
suicidal behaviors in the region (18, 19).
In Southeast Asia, a high prevalence of tobacco (smoking and
smokeless) use in the general population has been observed (21).
This meta-analysis found a higher prevalence of chewing tobaccoTABLE 2 | Meta-regression analysis exhibiting pooled prevalence of mental disorders in South Asian countries.
Covariate Coefficient Confidence Interval P-value Heterogeneity
95% Lower 95% Upper
Intercept −2.2725 −2.9563 −1.5887 <0.001
India 0.1364 −0.5936 0.8664 0.7143 Q = 54.84, df = 4, p ≤ 0.001
Nepal 0.9301 0.1205 1.7396 0.0243 Q = 54.84, df = 4, p ≤ 0.001
Pakistan 1.9675 1.1501 2.7848 <0.001 Q = 54.84, df = 4, p ≤ 0.001
Sri Lanka 0.9745 0.0414 1.9076 0.0407 Q = 54.84, df = 4, p ≤ 0.001September 2020 |R square = 15%.TABLE 1 | Pooled prevalence of mental disorders in South Asia.
Outcome Pooled prevalence (95% CI) Data points Sample size I2 Q P
Any disorder* 14.2% (12.9% to 15.7%) 394 8,63,657 99.67% 100,099.20 <0.001
Depression 26.4% (23.6% to 29.4%) 135 173,449 99.53% 28,447 <0.001
Alcohol abuse 13% (0.09% to 0.19%) 43 107,893 99.79% 20,683 <0.001
Anxiety 26% (0.19% to 0.34%) 36 70,058 99.57% 8,038.08 <0.001
Tobacco smoking 18.6% (14.3% to 24.0%) 34 84,965 99.58% 7,934.68 <0.001
PTSD 17.2% (11.0% to 25.9%) 21 42,298 99.55% 4,457.19 <0.001
Mixed anxiety and depression 28.4% (13.9% to 49.3%) 13 11,102 99.41% 2,043.01 <0.001
Suicidal behaviors 6.4% (3.1% to 12.4%) 13 25,043 99.41% 2,041 <0.001
Opiates 0.8% (0.2% to 2.5%) 12 37,304 99.06% 1,175.12 <0.001
Tobacco chewing 21.0% (14.0% to 3.03%) 10 10,586 98.49% 852.95 <0.001
Cannabis 0.03% (0.015% to 0.07%) 9 10,977 97.48% 317.52 <0.001
GAD 2.9% (0.3% to 26.5%) 5 31,682 99.77% 1,698.73 <0.001
Bipolar 0.6% (0.3% to 0.01%) 4 7,197 78.21% 13.77 0.003
IV Drug abuse 2.5% (0.1% to 32.1%) 4 15,049 99.72% 1,062.44 <0.001
Panic disorder 0.01% (0.05% to 0.3%) 4 28,087 95.43% 65.67 <0.001
Stimulants 0.9% (0.5% to 1.6%) 4 1,414 0% 1.09 0.78
OCD 1.6% (0.4% to 5.5%) 3 8,784 96.57% 58.29 <0.001
Phobias 1.8% (0.4% to 7.1%) 3 27,754 98.16% 108.88 <0.001Volume 11 | Article*Pooled estimate after adjusting for publication bias = 11.31% (10.05% to 12.69%)573150
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Asian countries. These results were similar to the findings of a
literature review from 1986 to 2010 showing a smoking
prevalence (median) was highest in Central/Eastern Europe
(37%), followed by Africa (29%), Central and South America
(25%), and Asia (17.5%) (22). Unlike developing countries,
South Asian countries lack an effective framework to facilitate
the people who chew or smoke tobacco to quit or national-level
strategies to control tobacco through policy approaches (23).
Among the illicit use of substances, alcohol dependence is the
most prevalent substance use disorder in South Asia, with a
prevalence of 13%, which is consistent with previously conducted
studies (24). While the most common drug use disorders in
South Asia were cannabis dependence (3%) and IV drugs (2.5%),Frontiers in Psychiatry | www.frontiersin.org 6the rates of alcohol dependence are relatively lower than those
reported in the Global Burden of Disease Study which reported
32.5% [95% uncertainty interval (UI) 30.0–35.2] of people
globally were current drinkers (24). This disparity in findings
may be due to different social structure in Muslim countries in
South Asia which prohibit the use of alcohol (24). The higher
prevalence of IV drug abuse (2.5%) in our analysis was
particularly alarming. In comparison, the global estimated
prevalence in 2015 was 0.33%, with an estimated 15.6 million
people (95% UI 10·2–23·7 million) injected drugs (25). These
results are alarming and explain the increase in diseases spread
by the intravenous route in the South Asian countries (25). On
the other hand, opiates and stimulant use were less common;
0.8% and 0.9%, respectively in our study.TABLE 3 | Subgroup analyses presenting several factors associated with the prevalence of CMDs in included in studies.
Group Pooled prevalence Lower limit Upper limit Q-value df (Q) P-value
Method for identification of CMD
Diagnostic 5.22% 4.27% 6.37% 139.23 1.00 <0.001
Questionnaire 19.14% 17.38% 21.02%
Study setting
Community 13.05% 11.74% 14.49% 31.71 3.00 <0.001
Healthcare setting 29.01% 21.25% 38.24%
Other 26.53% 17.38% 38.26%
Refugee Settings 7.19% 3.19% 15.40%
Sampling Method
Non-random 0.19 0.16 0.22 26.18 1.00 <0.001
Random 0.11 0.10 0.13
Study design
Cross-sectional 13.93% 12.61% 15.35% 7.62 1.00 0.01
Longitudinal 30.52% 17.91% 46.94%
Background of participants
Mixed 14.37% 12.04% 17.06% 56.40 5.00 <0.001
National 18.18% 12.58% 25.53%
Provincial 1.91% 1.03% 3.51%
Rural 14.12% 10.96% 18.00%
Semi-urban 36.58% 13.84% 67.43%
Urban 17.47% 15.05% 20.18%September 2020 | Volume 11 | ArticleFIGURE 2 | Funnel plot exhibiting publication bias in the studies.573150
Naveed et al. Prevalence of CMDs in South-AsiaExplanation of Findings
The variation in the prevalence of mental disorders in different
South Asian countries is speculated to be due to varying levels of
psychosocial, cultural, and political stressors. Increasing inflation
levels leading to economic stress, transitioning urban
communities, inter-religious, sectarian, and ethnic violence,
and war hysteria in countries such as India and Pakistan are
recent examples of these stressors (26–28). In addition to these
factors, the contribution of individual-level factors such as
resilience, alexithymia, and “trait” markers of individuals to
behavioral health and functionality needs to be considered
(29–32).
Recommendations for Future Practice
It is essential to improve the mental health services in South Asia,
which will require further well-designed epidemiological and
clinical research examining psychopathology of diverse
population groups in this region. Moreover, public education
and awareness campaigns on mental health conditions should be
undertaken to ameliorate the substantial public health burden in
South Asian countries. There should also be public awareness
programs to convey the adverse long-term effects of tobacco,
alcohol, and other illegal drugs. Also, treatment centers at the
community level for drug addictions should be set up. In these
discourses, evidence-based multipronged interventions found to
be effective in other contexts (33–35) may inform the
development and implementation of culturally appropriate
mental health interventions in this region.
Legislations and mental health laws have significant
shortcomings such as the lack of emphasis on human rights
and community-based mental health care approaches. Moreover,
there are major flaws in the implementation of these legislations.
Therefore, mentally ill people continue to be vulnerable to
various types of abuse and violation of their rights in the
region (10). Additionally, there is a lack of comprehensive
approach toward mental health policies as most countries lack
the inclusion of substance use disorders in these policies (7, 10).
In comparison to developed countries, common difficulties in
this region include poor constitutional guarantees for proper
health services, inadequate attention to civil and political rights,
criminalization of symptoms of mental health symptoms such as
suicide, and different cultural norms (10). Reform of mental
health legislation plays a significant role along with increased
trained manpower, improved resource allocation, and improved
services (10). It is important to perform the needs assessment of
the community for resource allocation and targeted community-
based efforts.LIMITATIONS AND RECOMMENDATIONS
FOR RESEARCH
This meta-analysis has several limitations; therefore, its results
should be interpreted with caution. Most of the included studies
used screening instruments rather than diagnostic tools.Frontiers in Psychiatry | www.frontiersin.org 7Moreover, it was difficult to compare data from the selected
studies due to differences in settings (clinic vs. community-
based), different assessment tools, and the different scales used
to determine the psychiatric disorders. Also, our review may
have been subject to selection and publication bias as we were
unable to contact the experts and collect unpublished materials
or access any grey literature that may have met the criteria for
this review.
Detailed analyses in our report primarily show that a high
proportion of studies had poor study design, for instance,
employing non-probabilistic sampling procedures, the use of
screening instruments rather than diagnostic tools, and limited
to a smaller study site. Although the present pooled analyses
show high prevalence rates of different CMDs, we recommend
future research employing diagnostic interviews to diagnose
mental disorders and recruiting participants in multiple
community settings with appropriate sample size calculation,
to yield precise prevalence estimates.CONCLUSION
This systematic review and meta-analysis found a high
prevalence of CMDs in South Asian countries. Among the
eight nations in this region, Pakistan had the highest
prevalence of CMDs. Also, the epidemiological burden of
different diseases affects diverse population groups at varying
levels, which need further research on how different risk factors
contribute to such a high prevalence of mental disorders in South
Asia. This study provides cumulative baseline evidence on the
prevalence of CMDs and informs an urgent need for effective
policymaking and multipronged interventions that are culturally
appropriate in the context of South Asia.DATA AVAILABILITY STATEMENT
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